Skip to main content
Clinical Trials/CTRI/2024/03/064342
CTRI/2024/03/064342
Not yet recruiting
Phase 3

A Comparative clinical study, to evaluate the efficacy of Haritakyadi yoga with Sarpagandha Mishrana in Essential Hypertension. - NI

DR KIRAN KUMAR BUDIHA0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: I10- Essential (primary) hypertensionHealth Condition 2: I10- Essential (primary) hypertension
Sponsor
DR KIRAN KUMAR BUDIHA
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
DR KIRAN KUMAR BUDIHA

Eligibility Criteria

Inclusion Criteria

  • 1\.Subjects fulfilling the Diagnostic criteria, for stage 1 cases of Essential Hypertension as per the guidelines of Eighth Joint National Committee.
  • 2\.Freshly diagnosed and untreated case of Essential Hypertension.
  • 3\.Old Cases who are on Antihypertensive medications with flush out period of 7 days.

Exclusion Criteria

  • 1\.Patients with Stage 2 Hypertension, SBP more than 160 and DBP more than 100 will be excluded.
  • 2\.Patients with Secondary hypertension will be excluded.
  • 3\.Patient with Malignant and Accelerated hypertension will be excluded.
  • 4\.Hypertension associated with end organ damage such as Vasculopathies, cerebrovascular damage, Heart disease, Neuropathies and other systemic illness will be excluded.
  • 5\.Patents with Uncontrolled Diabetes mellitus, RBS more than 300 mg per dl will be excluded.
  • 6\.Pregnant and lactating women will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials